SOX9 is a dose-dependent metastatic fate determinant in melanoma

SOX9 is a dose-dependent metastatic fate determinant in melanoma

Abstract Background In this research, we aimed to resolve contradictory results whether SOX9 plays a positive or negative role in melanoma progression and determine whether SOX9 and its closely related member SOX10 share the same or distinct targets in mediating their functions in melanoma. Methods...

Full description

Bibliographic Details
Main Authors: Xintao Yang, Rui Liang, Chunxi Liu, Jessica Aijia Liu, May Pui Lai Cheung, Xuelai Liu, On Ying Man, Xin-Yuan Guan, Hong Lok Lung, Martin Cheung
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
SOX9; SOX10
NEDD9
RHOA
RAC1
Melanoma
Metastatic
Online Access:http://link.springer.com/article/10.1186/s13046-018-0998-6

Internet

http://link.springer.com/article/10.1186/s13046-018-0998-6

Similar Items